MBOT — Microbot Medical Balance Sheet
0.000.00%
- $146.75m
- $114.07m
- 37
- 21
- 54
- 29
Annual balance sheet for Microbot Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 24.6 | 15.5 | 8.21 | 6.38 | 5.47 |
| Net Total Receivables | 0.07 | 0.174 | 0.103 | 0.061 | 0.089 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 25.3 | 15.9 | 8.81 | 7.92 | 5.82 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.03 | 0.888 | 0.723 | 0.406 | 0.212 |
| Total Assets | 26.3 | 16.8 | 9.54 | 8.33 | 6.03 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.34 | 1.98 | 2.07 | 3.79 | 2.46 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1.97 | 2.39 | 2.25 | 3.83 | 2.5 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Total Equity | 24.3 | 14.4 | 7.29 | 4.5 | 3.53 |
| Total Liabilities & Shareholders' Equity | 26.3 | 16.8 | 9.54 | 8.33 | 6.03 |
| Total Common Shares Outstanding |